Cargando…
Author Correction: Clinical molecular subtyping reveals intrinsic mesenchymal reprogramming in gastric cancer cells
Autores principales: | Jang, Eunji, Shin, Min-Kyue, Kim, Hyunki, Lim, Joo Yeon, Lee, Jae Eun, Park, Jungmin, Kim, Jungeun, Kim, Hyeseon, Shin, Youngmin, Son, Hye-Young, Choi, Yoon Young, Hyung, Woo Jin, Noh, Sung Hoon, Suh, Jin-Suck, Sung, Ji-Yong, Huh, Yong-Min, Cheong, Jae-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317993/ https://www.ncbi.nlm.nih.gov/pubmed/37322356 http://dx.doi.org/10.1038/s12276-023-01037-6 |
Ejemplares similares
-
Clinical molecular subtyping reveals intrinsic mesenchymal reprogramming in gastric cancer cells
por: Jang, Eunji, et al.
Publicado: (2023) -
Single patient classifier as a prognostic biomarker in pT1N1 gastric cancer: Results from two large Korean cohorts
por: Choi, Yoon Young, et al.
Publicado: (2021) -
Modification of the TNM Staging System for Stage II/III Gastric Cancer Based on a Prognostic Single Patient Classifier Algorithm
por: Choi, Yoon Young, et al.
Publicado: (2018) -
FoxM1-dependent and fatty acid oxidation-mediated ROS modulation is a cell-intrinsic drug resistance mechanism in cancer stem-like cells
por: Choi, Hae-Ji, et al.
Publicado: (2020) -
Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial
por: Roh, Chul Kyu, et al.
Publicado: (2019)